Quarterly report [Sections 13 or 15(d)]

LIQUIDITY (Details Narrative)

v3.25.3
LIQUIDITY (Details Narrative) - USD ($)
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 31, 2025
Jul. 30, 2025
Feb. 28, 2025
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Subsidiary, Sale of Stock [Line Items]                      
Net loss       $ 1,040,254   $ 1,401,663   $ 6,637,948 $ 7,358,143    
Cash used in operating activities               11,031,943 $ 6,200,147    
Working capital deficit       27,574,533       27,574,533      
Accumulated deficit       $ 81,005,957       $ 81,005,957   $ 74,368,009  
Proceeds from preferred stock issued $ 3,136,533           $ 2,995,002       $ 11,500,000
Common stocks issued for cash under ATM     $ 3,954,940   $ 1,835,874         $ 3,544,689  
Proceeds from issuance of public offering   $ 37,100,000                  
Over-Allotment Option [Member]                      
Subsidiary, Sale of Stock [Line Items]                      
Over-allotment option description               Underwriter exercised the Over-Allotment Option in full to purchase 838,851 shares of Common Stock, generating additional net proceeds of approximately $4.7 million.